<![CDATA[Toric multifocal intraocular lenses (TMIOLs) are an important innovation in cataract treatment, especially in patients with astigmatism. TMIOLs are designed to improve multifocal vision while correcting astigmatism, providing significant benefits to patients after cataract surgery. A literature search was conducted in four major databases, namely PubMed, Scopus, Google Scholar, and Cochrane. Included studies were observational studies published between 2010 and 2023. Search keywords included “multifocal toric intraocular lens” OR “toric IOL” AND “visual outcomes” OR “patient satisfaction.” Inclusion criteria included adult patients after cataract surgery with or without astigmatism who underwent TMIOLs implantation. A total of five relevant studies were analyzed. The results showed that TMIOLs significantly improved distance and near visual acuity without additional aids, with a patient satisfaction rate of 94%. Side effects such as glare and halos were reported in a small number of patients, but newer lens technologies are able to minimize these effects. The use of TMIOLs has been shown to be effective in improving visual efficacy and patient satisfaction levels after cataract surgery. Despite the potential for side effects, the overall benefits of TMIOLs outweigh the risks. Further research is needed to evaluate long-term efficacy and develop better lens technologies]]>
Copyrights © 2024
